Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01689272
Other study ID # 0111RK00337
Secondary ID
Status Completed
Phase Phase 4
First received September 17, 2012
Last updated February 10, 2015
Start date May 2011
Est. completion date December 2013

Study information

Verified date February 2015
Source Republican Scientific Center for Emergency Medicine
Contact n/a
Is FDA regulated No
Health authority Kazakhstan: Ethical CommissionKazakhstan: Ministry of Public Health
Study type Interventional

Clinical Trial Summary

The purpose of the study:

- To estimate the role of morphological, clinical, biochemical and imaging studies at stages of kidney transplantation (medical therapy, explantation, preservation, transplantation).

- To improve the ways of preserving optimal functional parameters of renal transplants.


Description:

Terminal chronic renal failure (ESRD) as a result of almost any chronic kidney disease develops due to progressive loss of nephrons. This state is characterized by a gradual deterioration of the functional abilities of not only the kidneys, but also the whole body. Currently, ESRD is among the first ten causes of mortality .

Transplantation of donor organs is the only radical treatment for various diseases of the terminal, for patients with a fatal prognosis.

Kidney transplantation has allowed not only save lives, but also to return to normal life, tens of thousands of people. Survival of renal transplant recipients is growing.

Despite the progress made in many clinics worldwide in recent years in the field of transplantation, kidney transplantation, does not settle the problem of reperfusion injury and the associated post-transplant dysfunction with the absence of clear indicators of morphological, clinical, biochemical and instrumental methods to assess functional reserve of organs that remain relevant and meaningful.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date December 2013
Est. primary completion date September 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- recipients-patients with end-stage renal disease;

- donor healthy people without absolute contraindications to the kidney transplantation;

- donor and recipients who are both in the genetic and non-genetic related to each other.

- obligatory immunological compatibility by HLA-phenotyping provided that the donor and recipient are not relatives with each other;

- negative result of cross-match between donors and recipients;

- presence of pre-existing lymphotoxic antibodies in a recipient less than 50%;

- absence of standard absolute contraindications in a donor and in a recipient for surgeric intervention.

Age is 18-60 years.

Exclusion Criteria:

- patients with absolute contraindications to surgery: diseases of organs and systems having a threating risk to the life of donor and recipient during and after surgery;

- immunological incompatibility between donor and recipient;

- high level of pre-existing lymphotoxic antibodies in a recipient more than 50%, uncorrected by Therapy;

- donor age is under 18 and over 60 years;

- incapable persons;

- absence of a notarized consent form to kidney transplantation;

- presence of the active phase of viral infection with hepatitis B and C;

- positive results of blood tests for HIV/AIDS, syphilis;

- patients with severe concomitant pathology of kidneys, (or) heart and (or)liver.

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Kidney Transplantation from alive relative donor
Donor kidney sampling, preservation, transport and transplantation

Locations

Country Name City State
Kazakhstan Republican Scientific Center for Emergency Medicine Astana

Sponsors (1)

Lead Sponsor Collaborator
Republican Scientific Center for Emergency Medicine

Country where clinical trial is conducted

Kazakhstan, 

Outcome

Type Measure Description Time frame Safety issue
Other Pre-Operative Patients Health Status: Donor and Recipient Patient-donor health status.
Concomitant somatic pathology of a patient-recipient.
Time for Kidney transplantation.
For 1 week Yes
Primary Functional Reserve Estimation of Donor Kidney Graft survival is assessed on the following criteria:
The duration of the functioning graft
Clinical, laboratory and device functioning graft.
Morphological and histological study of the stages of transplantation (for withdrawal, before implantation) and the post-transplant period (with the threat of rejection.) Study of the blood recipient: Laboratory tests of blood recipient: biochemical analysis, the composition of the electrolyte, acid-base status, the level of immunosuppressants. Immunological typing for HLA-system. Cross-typing of donor and recipient, the level of pre-existing limfotsitotoksicheskih antibodies in the recipient.Patients survival.
for 12 months Yes
Secondary Clinical and Laboratory,Imaging Parameters Intraoperational Macroscopic Description of signs of kidney ischemia: turgor, colour, consistency of transplanted kidney, pulse characteristics of renal artery.
Signs of graft rejection: increasing of temperature, blood pressure, the levels of waste products (blood creatinine, blood urea).
From 2 hours to 7 days Yes
See also
  Status Clinical Trial Phase
Completed NCT04087213 - Study of HemoCareā„¢ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD N/A
Completed NCT02207088 - Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease Phase 3
Not yet recruiting NCT03090828 - Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease N/A
Completed NCT02237521 - The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease N/A
Withdrawn NCT01691196 - Inflammation in Peritoneal Dialysis Patients: Effect of Obesity
Completed NCT01394341 - Liraglutide Treatment to Patients With Severe Renal Insufficiency Phase 4
Active, not recruiting NCT00247507 - The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients Phase 4
Completed NCT00307463 - Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation Phase 4
Recruiting NCT00155363 - Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis Phase 4
Completed NCT00234156 - The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers N/A
Completed NCT00586131 - Arterial pH and Total Body Nitrogen Balances in APD Phase 4
Active, not recruiting NCT05027074 - Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007) Phase 2
Recruiting NCT04575077 - The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation
Enrolling by invitation NCT05001009 - Goals of Care Conversations Study N/A
Completed NCT01756508 - Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury Phase 2
Recruiting NCT03862859 - The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis Phase 4
Terminated NCT03661229 - Cardiovascular and Respiratory Assessment Using Biometric Signals in a Non-contact Monitoring Device N/A
Completed NCT03288922 - Protein-bound Toxin Removal Between Limited Blood Flow Super High-flux Online HDF and High-Efficiency Online HDF N/A
Completed NCT02360748 - A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients N/A
Completed NCT02572882 - Gut Microbiome and p-Inulin in Hemodialysis N/A